Literature DB >> 20872206

A combination procedure with thrombolytic therapy and balloon dilatation for portal vein thrombus enables the successful performance of antiviral therapy after a living-donor liver transplantation: report of a case.

Koji Hamasaki1, Susumu Eguchi, Mitsuhisa Takatsuki, Kensuke Miyazaki, Akihiko Soyama, Masaaki Hidaka, Kosho Yamanouchi, Yoshitsugu Tajima, Takashi Kanematsu.   

Abstract

This report presents a case of portal vein thrombosis possibly caused by anastomotic stricture after living-donor liver transplantation. The patient underwent systemic thrombolytic therapy with tissue plasminogen activator and subsequent balloon dilatation of the stenotic lesion, and both were successful. These procedures allowed the patient to receive antiviral therapy to improve the pancytopenia, leading to a sustained virological response.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20872206     DOI： 10.1007/s00595-009-4159-6

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  15 in total

1.  Venous complications after orthotopic liver transplantation.

Authors:  U Settmacher; N C Nüssler; M Glanemann; R Haase; M Heise; W O Bechstein; P Neuhaus
Journal:  Clin Transplant       Date:  2000-06       Impact factor: 2.863

2.  Treatment of portal venous thrombosis with selective superior mesenteric artery infusion of recombinant tissue plasminogen activator.

Authors:  E A Henao; W Todd Bohannon; M B Silva
Journal:  J Vasc Surg       Date:  2003-12       Impact factor: 4.268

3.  Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation.

Authors:  Toyomichi Shibata; Kyo Itoh; Takeshi Kubo; Yoji Maetani; Toshiya Shibata; Kaori Togashi; Koichi Tanaka
Journal:  Radiology       Date:  2005-04-21       Impact factor: 11.105

4.  Systemic thrombolytic therapy for late-onset portal vein thrombosis after living-donor liver transplantation.

Authors:  Mitsuhisa Takatsuki; Chao-Long Chen; Yaw-Sen Chen; Yu-Fan Cheng; Tung-Liang Huang
Journal:  Transplantation       Date:  2004-04-15       Impact factor: 4.939

5.  Role of interventional radiology in the management of vascular complications after liver transplantation.

Authors:  C Vignali; R Cioni; P Petruzzi; A Cicorelli; I Bargellini; M Perri; L Urbani; F Filipponi; C Bartolozzi
Journal:  Transplant Proc       Date:  2004-04       Impact factor: 1.066

6.  Portal vein complications after adult-to-adult living donor liver transplantation.

Authors:  Yusuke Kyoden; Sumihito Tamura; Yasuhiko Sugawara; Yuichi Matsui; Junichi Togashi; Junichi Kaneko; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Transpl Int       Date:  2008-09-01       Impact factor: 3.782

Review 7.  Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis.

Authors:  Renan Uflacker
Journal:  Tech Vasc Interv Radiol       Date:  2003-03

Review 8.  Toward 300 liver transplants a year.

Authors:  Sung Gyu Lee; Shin Hwang; Ki Hun Kim; Chul Soo Ahn; Dug Bok Moon; Tae Yong Ha; Ki Won Song; Dong Hwan Chung
Journal:  Surg Today       Date:  2009-04-30       Impact factor: 2.549

9.  Early posttransplantation portal vein stenosis following living donor liver transplantation: percutaneous transhepatic primary stent placement.

Authors:  Gi-Young Ko; Kyu-Bo Sung; Hyun-Ki Yoon; SungGyu Lee
Journal:  Liver Transpl       Date:  2007-04       Impact factor: 5.799

10.  Evolution of living donor liver transplantation over 10 years: experience of a single center.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Masaaki Hidaka; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549
View more
  1 in total

1.  Huge inflammatory pseudotumor of the spleen with postoperative portal vein thrombosis: report of a case.

Authors:  Norifumi Tsutsumi; Hirofumi Kawanaka; Shohei Yamaguchi; Masahiro Sakai; Seiya Momosaki; Kazuya Endo; Koji Ikejiri
Journal:  Surg Today       Date:  2011-12-10       Impact factor: 2.549
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.